HempFusion Is the Top Performing Topical CBD Brand at Major Food-Drug Mass Retailer
March 09 2021 - 7:05AM
Business Wire
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO)
("HempFusion" or the "Company"), a leading health and wellness CBD
company utilizing the power of whole-food hemp nutrition, is
pleased to announce that its OTC Topical Products have ranked
number one in both sales dollars and units sold at a major Food
& Drug Mass (“FDM”) retailer according to a recent NielsenIQ
share report.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210309005314/en/
HempFusion OTC Topicals (Photo: Business
Wire)
“Ranking #1 across all measured data, including #1 in sales by
dollar volume and #1 by SKU volume, is a tremendous honor.
Consumers are validating our team’s mission of providing best in
class products that adhere to the highest standards of regulatory
compliance,” commented Jason Mitchell, N.D., the Company’s
Co-Founder and Chief Executive Officer. “Since its inception in
2015, HempFusion’s goal has been to develop and provide consumers
with the highest quality products on the market, without
compromise. We are meticulous in sourcing the right raw materials,
ingredients, and delivery methods to help consumers live a more
balanced lifestyle, and the FDM channel provides us with an
unprecedented distribution opportunity to help us reach those
consumers,” continued Dr. Mitchell.
The FDM channel represents the largest sales opportunity for the
Company’s products by dollar volume. According to Brightfield
Group, in Q3, 2020, 41% of CBD consumers reported they recently
started shopping in-store again for products that contain CBD; and
CBD specialty retailers and pharmacies saw an uptick in
consumer-reported purchasing. HempFusion looks forward to
leveraging this initial FDM channel success with other major
retailers across the United States and abroad.
“The Food & Drug Mass channel has been a significant focal
point of HempFusion’s strategic distribution plan, and to see our
products quickly become the top-selling CBD brand according to
NielsonIQ, in this entire Top 5 FDM Grocery retail chain, is
incredibly exciting,” commented Jon Visser, the Company’s Chief
Revenue Officer. “This third-party data demonstrates that our
overall strategy of producing premium products with a focus on
regulatory compliance, consumer messaging, and the right price
point is resonating very well with category shoppers. We believe
this is just the beginning. We are in continued talks with other
top FDM retailers both domestically and internationally to ensure
this data is widely available,” continued Visser.
ABOUT HEMPFUSION
HempFusion is a leading health and wellness CBD company
utilizing the power of whole-food hemp nutrition. HempFusion
distributes its family of brands, including HempFusion, Probulin
Probiotics, Biome Research, and HF Labs, to approximately 4,000
retail locations across all 50 states of the United States and
select international locations. Built on a foundation of regulatory
compliance and human safety, HempFusion’s diverse product portfolio
comprises 48 SKUs including tinctures, proprietary FDA Drug Listed
Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and
more. With a strong focus on research and development, HempFusion
has an additional 30 products under development. HempFusion is a
board member of the US Hemp Roundtable, and HempFusion’s
wholly-owned subsidiary, Probulin Probiotics, is one of the
fastest-growing probiotics companies in the United States,
according to SPINs reported data. HempFusion’s CBD products are
based on a proprietary Whole Food Hemp Complex™ and are available
in-store or by visiting HempFusion online at www.hempfusion.com or
www.probulin.com.
Follow HempFusion on Twitter, Facebook and Instagram and
Probulin on Twitter, Facebook and Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements and
forward-looking information within the meaning of Canadian
securities legislation (collectively, “forward-looking
statements“) that relate to HempFusion’s current expectations
and views of future events. Any statements that express, or involve
discussions as to, expectations, beliefs, plans, objectives,
assumptions or future events or performance (often, but not always,
through the use of words or phrases such as “will likely result”,
“are expected to”, “expects”, “will continue”, “is anticipated”,
“anticipates”, “believes”, “estimated”, “intends”, “plans”,
“forecast”, “projection”, “strategy”, “objective” and “outlook”)
are not historical facts and may be forward-looking statements and
may involve estimates, assumptions and uncertainties which could
cause actual results or outcomes to differ materially from those
expressed in such forward-looking statements. No assurance can be
given that these expectations will prove to be correct and such
forward-looking statements included in this news release should not
be unduly relied upon. These statements speak only as of the date
of this news release. In particular and without limitation, this
news release contains forward-looking statements relating to the
Company’s plans to leverage FDM sales, the Company’s broader retail
distribution plans and the Company’s other plans, focus and
objectives.
Forward-looking statements are based on a number of assumptions
and are subject to a number of risks and uncertainties, many of
which are beyond HempFusion’s control, which could cause actual
results and events to differ materially from those that are
disclosed in or implied by such forward-looking statements. Such
risks and uncertainties include, but are not limited to, the impact
and progression of the COVID-19 pandemic and other factors set
forth under “Forward-Looking Statements” and “Risk Factors” in the
final long form prospectus of the Company dated December 17, 2020
and available under the Company’s profile on SEDAR at
www.sedar.com. HempFusion undertakes no obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as may be required
by law. New factors emerge from time to time, and it is not
possible for HempFusion to predict all of them or assess the impact
of each such factor or the extent to which any factor, or
combination of factors, may cause results to differ materially from
those contained in any forward-looking statement. Any
forward-looking statements contained in this news release are
expressly qualified in their entirety by this cautionary
statement.
Neither the TSX nor its Regulation Services Provider (as that
term is defined in the policies of the TSX) accepts responsibility
for the adequacy or accuracy of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210309005314/en/
Jason Mitchell, N.D. Chief Executive Officer and Director Email:
ir@hempfusion.com Phone: 416-803-5638
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Aug 2024 to Sep 2024
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Sep 2023 to Sep 2024